NCT03757585View on ClinicalTrials.gov

Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

May 6, 2024

Study Completion Date

May 6, 2024

Conditions
Non-verbal Learning DisorderAutism Spectrum DisorderAutism
Interventions
DRUG

Open-label Treatment with Omega-3 Fatty Acids + Inositol

Open-label Treatment with Omega-3 Fatty Acids + Inositol

DRUG

Open-label Treatment with N-acetylcysteine

Open-label Treatment with acetylcysteine

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Demarest Lloyd Jr. Foundation

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT03757585 - Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) | Biotech Hunter | Biotech Hunter